# Vaseem Mahboob

Type: Person

Source: GetYourBrief — https://getyourbrief.com/entity/vaseem-mahboob
Canonical HTML page: https://getyourbrief.com/entity/vaseem-mahboob

## Timeline

- **2026-04-30**: Expansion Target — Goal to reach 130 active sales territories by fiscal year-end
- **2026-03-17**: Earnings Release — Announced 63% revenue growth and VA hospital network access
- **2026-01-31**: Q3 Fiscal End — Closed third quarter with 100 active sales territories
- **2025-12-01**: Equity Offering — Completed capital raise to bolster cash position to $291M

## Recent coverage (3 stories, network-wide)

### Kestra Medical Reports 63% Revenue Surge on Assure System Adoption
2026-03-18 00:41:09 · Sector: finance · Sentiment: Positive · Impact: 6/10 · Sources: 2

Kestra Medical (KMTS) delivered a strong Q3 2026 performance, highlighted by a 63% year-over-year revenue increase and the ninth consecutive quarter of gross margin expansion. While net losses widened to $34.2 million due to aggressive sales force expansion, the company secured critical access to the VA Federal Supply Schedule and expanded its Florida Medicaid footprint.
Full story: https://getfinancebrief.com/story/kestra-medical-q3-2026-earnings-analysis

### Kestra Medical Surges 63% on Assure Growth and Strategic VA Expansion
2026-03-18 00:40:35 · Sector: bio · Sentiment: Positive · Impact: 6/10 · Sources: 2

Kestra Medical reported a 63% year-over-year revenue increase to $24.6 million in Q3 2026, driven by record prescriptions for its Assure wearable cardioverter defibrillator. The company significantly expanded its market access through a new U.S. Department of Veterans Affairs contract and improved Medicaid coverage in Florida.
Full story: https://getbiobrief.com/story/kestra-medical-kmts-q3-2026-earnings-analysis

### Kestra Medical Reports 63% Revenue Growth Amid VA and Medicaid Expansion
2026-03-18 00:40:02 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 2

Kestra Medical (KMTS) delivered a robust Q3 2026 with $24.6 million in revenue, driven by a 58% surge in Assure system prescriptions. Despite a widening net loss of $34.2 million, the company secured critical access to the VA Federal Supply Schedule and expanded its Florida Medicaid footprint.
Full story: https://gethealthbrief.com/story/kestra-medical-q3-2026-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.